Obviously, if you believe, like me, that equities are in the process of imploding and the best days are over and the Big Kahuna is just ahead of us within 24 months, capital allocation is of utmost priority.
To illustrate, 2 scenarios - Scenario 1 where minimal capital say 20% is deployed for opportunistic trades (with stop loss discipline of 20%) and the rest in bonds and cash and Scenario 2 the conventional wisdom of staying in equities for the long ride with up to 70% in equities.
Column 1 Column 2 Column 3 Column 4 0 SCENARIO 1 1 CAPITAL $ 100,000 2 ALLOCATION 20% OPPORTUNISTIC MANAGED TRADES (SHORT TERM) 3 20% CORP BONDS E.G VLWHA 6.25% 4 60% CASH 5 6 ASSET CLASS BEST RETURNS WORSE RETURNS 7 ST OPP TRADES 20.0% -9.0% 8 BONDS 6.25% 5.00% 9 CASH 2.0% 2.0% 10 COMPOSITE 6.5% 0.4% 11 12 SCENARIO 2 CONVENTIONAL WISDOM 13 CAPITAL $ 100,000 14 ALLOCATION 50% BLUE CHIP EQUITIES (LONG TERM HOLD) 15 20% SMALL CAPS EQUITIES (LONG TERM HOLD) 16 30% CASH 17 ASSET CLASS BEST RETURNS WORSE RETURNS 18 BLUE CHIP 5.0% -25.0% 19 SMALL CAPS 15.0% -50.0% 20 CASH 2.0% 2.0% 21 COMPOSITE 6.1% -21.9%
Scenario 1 could well offer a cap on negative returns when stocks suffer losses but its returns can be just as good on best case basis.
To achieve a 20% managed short term opportunity, it can involve 2 > 50% return stocks and 2 -20% return stocks (stop loss) while on the worse case basis, 2 single digit <10% return stocks and 2 -25% return stocks. Under managed basis, the key is to know when to cut loss and minimise a trade that has gone pear shape (no denial in works). And to let your hero run a bit more but know when exactly exuberance got out of hand - examples have been BIT and 4DS in recent times.
*The above is illustrative only and not an advice on money management or financial planning to suit your own circumstances.
- Forums
- ASX - General
- Its Over
Its Over, page-403
-
- There are more pages in this discussion • 3,028 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online